Embryoid%20Bodies%20From%20Embryonic%20Stem%20Cells%20In-vitro - PowerPoint PPT Presentation

About This Presentation
Title:

Embryoid%20Bodies%20From%20Embryonic%20Stem%20Cells%20In-vitro

Description:

Embryoid Bodies From Embryonic Stem Cells In-vitro Robert Christensen Biology Department Eastern Connecticut State University Endoderm Specific Gene Expression in ... – PowerPoint PPT presentation

Number of Views:136
Avg rating:3.0/5.0
Slides: 18
Provided by: Robert2691
Category:

less

Transcript and Presenter's Notes

Title: Embryoid%20Bodies%20From%20Embryonic%20Stem%20Cells%20In-vitro


1
Embryoid Bodies From Embryonic Stem Cells In-vitro
  • Robert Christensen
  • Biology Department
  • Eastern Connecticut State University

2
EndodermSpecific Gene Expression in Embryonic
StemCells Differentiated To Embryoid Bodies
  • Experimental Cell Research 229 (1999) pp 27-34

Koichiro Abe, Hitoshi Niwa, Katsuro Iwase, Masaki
Takiguchi, Masataka Mori, Shin Ichi Abe, Kuniya
Abe, and Ken- Ichi Yamamura
3
Introduction
  • Cell lineages arise during development
  • ES cells have full developmental potential
  • EBs from ES cells
  • Ectodermal tissues
  • Mesodermal tissues
  • Endodermal tissues
  • EBs consist of
  • EBs resemble the embryo of the egg- cylinder
    stage
  • Neuronal cells
  • Cardiac muscle cells
  • Hematopoietic cells
  • Yolk sac cells
  • Later stages EBs are composed of

4
  • Past studies showed specific changes in
    expression of endoderm marker genes
    during EB development and suggested that EB
    formation could be considered an in-vitro model
    for endoderm differentiation.
  • This paper extended their analysis and
    systematically characterized temporal expression
    patterns of endoderm marker genes during EB
    formation.
  • RNA blot
  • Reverse transcription polymerase chain reaction
    (RT-PCR)
  • In-situ hybridization
  • The nature of endoderm differentiation in-vitro
    is discussed in relation to normal embryonic and
    extraembryonic development in-vivo.

5
Materials and Methods
  • Cell cultures
  • ES cell line, D3, cultured
  • Incubated 3 days in Dulbeccos modified eagles
    medium (DMEM)
  • 15 fetal calf serum
  • 0.1 mM 2-mercaptoethanol
  • 110 µg/ml sodium pyruvate
  • 4.5 mg/ml D-glucose
  • Is supplemented with 1000 units/ml recombinant
    murine leukemia inhibitory factor (LIF)

6
  • LIF was withdrawn
  • The cells were allowed to aggregate
  • The DMEM was changed every other day throughout
    the culture

7
Northern Blot Analysis
  • Total RNA prepared from undifferentiated ES
    cells, preaggregation ES cells, and EBs of
    various stages
  • 1 whole dish of EBs was used for isolation of
    total RNA
  • Samples were collected from undifferentiated ES
    cells, preaggregation phase cells, and EBs at
    days 0, 1, 2, 3, 4, 5, 7, 9, 11, 13, 15, and 18
  • RNA electrophoresed and transferred to Hybond-N
    membranes
  • Hybridizations performed and signals detected

8
RT-PCR
  • Total RNA from various stages, and adult mouse
    liver was treated with RNase-free DNase
  • cDNA synthesis
  • Parallel reaction performed without reverse
    transcriptase to assess presence of DNA
    contamination

9
Whole-mount in situ hybridization sectioning of
EBs
  • These experiments were carried out as described
    by Sasaki and Hogan
  • Stained EBs were refixed in paraformaldehyde and
    glutaraldahyde for 30 minutes
  • Then washed twice with PPT and placed in molten
    agarose, solidified, then sectioned

10
Molecular Probes
  • Xho I fragment of R1 used as ?-fetoprotein (AFP)
    probe
  • A fragment of Sma I Sac I fragment of pHF22.1
    used as a hepatocyte nuclear factor (HNF) probe
  • A 660-bp Pst I Pvu II fragment of pmPA1 was
    subcloned and used as a transthyretin (TTR) cDNA
    probe
  • A variant form of HNF1 (vHNF1) probe was
    synthesized by PCR using adult mouse liver cDNA
    as a template
  • Serum albumen (ALB) probe was also made by PCR

11
Results
  • vHNF1 and HNF4 transcript levels were very low in
    the undifferentiated, preaggregation and day 0
    EBs, then abruptly incresed at day 1
  • HNF3? began weak, but the expression level
    increased after day 1
  • TTR expression was still low at day 1, but
    increased rapidly thereafter
  • These results demonstrate that the activation of
    vHNF1, and HNF4 or HNF3? preceded the rise in TTR
    expression, beginning at day 1
  • At day 1, ES cells formed small compact cell
    aggregates, lacking morphologically distinct cell
    populations
  • Elevation of TTR levels around day 3 coincide
    with the appearance of primitive endodermal cells

12
These data show that all the serum protein genes
were activated at different stages, followed by a
strong increase in expression, and all the
transcription factor genes were not active in the
undifferentiated stem cells, and began to be
expressed in early phase differentiation.
13
  • The results of the northern blot and RT-PCR
    analyses demonstrated that endodermal cell
    differentiation occurred during the EB development
  • Two types of populations were expressed by day 5
  • Yolk-sac-like structures
  • Hematopoietic cells
  • The TTR messages were found only in the
    population of the EBs which began to form
    yolk-sac-like structures and were only found in
    the outer endodermal layer of the yolk-sac-like
    structures

14
This suggests that at least one of the endoderm
marker genes is predominantly expressed in the
outer layer of the yolk-sac-like structure during
EB development
15
The order of gene expression for the in vivo
studies is similar to that found in EB formation
in vitro
16
Conclusion
  • These data as a whole strongly suggest that
    development of EBs in vitro closely resembles the
    sequence of in vivo (normal) development of
    visceral yolk sac endoderm.
  • The ES cell in vitro differentiation system
    should be useful for analyzing molecular events
    concerning both extraembryonic and embryonic
    endoderm differentiation processes

17
The End
Write a Comment
User Comments (0)
About PowerShow.com